New radiation 'Smart Bomb' targets deadly brain cancer in global trial
NCT ID NCT07100730
Summary
This global Phase 3 trial is testing whether adding a new targeted radiation therapy (TLX101-Tx) to standard chemotherapy (lomustine) works better than chemotherapy alone for adults whose aggressive brain cancer (glioblastoma) has returned for the first time. The new therapy aims to deliver radiation directly to cancer cells. The study will compare the safety and effectiveness of the combination treatment against the current standard of care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Health
RECRUITINGMelbourne, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Gold Coast University Hospital
RECRUITINGGold Coast, Queensland, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal North Shore Hospital
NOT_YET_RECRUITINGSydney, Australia
Conditions
Explore the condition pages connected to this study.